Vivoo Vaginal pH Test
FDA Device Recall #Z-1266-2026 — Class II — November 22, 2025
Recall Summary
| Recall Number | Z-1266-2026 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 22, 2025 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Changchun Wancheng Bio-Electron Co., Ltd. |
| Location | Changchun, N/A |
| Product Type | Devices |
| Quantity | 3,000 |
Product Description
Vivoo Vaginal pH Test
Reason for Recall
Test strips and other tests including for near-patient testing, that require a 510(k) were distributed before they could be legally marketed to U.S. customers; devices may cause false or inaccurate diagnostic result by lay person and lead to inappropriate medical intervention.
Distribution Pattern
US Nationwide distribution in the states of TX, GA, CA.
Lot / Code Information
Name/Lot(Expiration): Vivoo Vaginal pH Test/2024032219(03/21/2026)
Other Recalls from Changchun Wancheng Bio-Electron Co., ...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1262-2026 | Class II | Male Fertility Sperm Test for Home Use (Cassette) | Nov 22, 2025 |
| Z-1263-2026 | Class II | Exploro Highly Sensitive Male Fertility / Sperm... | Nov 22, 2025 |
| Z-1265-2026 | Class II | Vivoo Protein Test | Nov 22, 2025 |
| Z-1257-2026 | Class II | LotFancy Urinary Tract Infection Urine (UTI) Te... | Nov 22, 2025 |
| Z-1261-2026 | Class II | S. Typhi/Para Typhi A Antigen | Nov 22, 2025 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.